Global Corneal Implants Market, By Type, By Surgery Method, By Application, By End-use, By Region & Segmental Insights Trends and Forecast, 2023 – 2031

  • Industry: Healthcare
  • Report ID: TNR-110-1034
  • Number of Pages: 420
  • Table/Charts : Yes
  • November, 2023
  • Base Year : 2024
  • No. of Companies : 12+
  • No. of Countries : 29
  • Views : 10081
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Corneal implants, also known as corneal inlays, are small devices surgically inserted into the cornea of the eye to correct vision problems like presbyopia. These implants alter the way light enters the eye, improving near vision. They offer a minimally invasive alternative to reading glasses for certain individuals with age-related vision changes. In terms of revenue, the global corneal implants market was worth US$ 402.5 Mn in 2022, anticipated to witness CAGR of 6.1% during 2023 – 2031.

Trends in the Global Corneal Implants Market

  • Presently, the corneal implants market is witnessing significant momentum due to ongoing advancements in material science. Researchers are continuously developing innovative materials that enhance the biocompatibility and durability of these implants. Novel biomaterials, like bioengineered polymers, are being explored to create more comfortable and long-lasting corneal implants. This trend is fostering the development of next-generation implants that promise improved patient outcomes and reduced risks of complications, driving the corneal implants market’s growth.
  • The corneal implants market is currently being reshaped by the adoption of 3D printing technology. Customization is a growing trend, with manufacturers using 3D printing to create personalized corneal implants tailored to each patient’s unique eye anatomy. This precise customization ensures a better fit and visual outcome. Additionally, 3D printing enables faster production, reducing lead times and making corneal implants more accessible to a broader patient base. This trend is revolutionizing the industry by offering tailored solutions for better vision correction.

Global Corneal Implants Market Revenue & Forecast, (US$ Million), 2015 – 2031

Synthetic corneas segment has gained popularity in recent years and is anticipated to be the fastest growing segment in the global corneal implants market during the forecast period. Innovations in biomaterials and surgical techniques have led to improved biocompatible synthetic corneas. This study observed an increasing number of successful cases utilizing synthetic corneal implants, offering a viable alternative to human donor corneas. Furthermore, the global shortage of donor corneas, with a persistent gap between supply and demand, is driving the demand for synthetic alternatives. This coupled with technological advancements, positions synthetic corneas as a fast-growing and increasingly reliable solution for patients with corneal disorders.

Keratoconus application segment had the highest share in the global corneal implants market in 2022 due to its prevalence and the inadequacy of traditional treatments. Keratoconus, a progressive corneal disease, affects a substantial population, with the study estimating that 1 in 2,000 individuals is affected. Many patients with advanced stages of Keratoconus require more than glasses or contact lenses for vision correction. Corneal implants, such as Intacs, have emerged as a valuable alternative, with the study recognizing their efficacy in stabilizing and improving vision. This high demand, driven by the unmet needs of Keratoconus patients, establishes the segment’s dominance in the market.

Asia Pacific is expected to witness the highest growth rate in the corneal implants market during the forecast period. The region accounts for a significant portion of the world’s population, with a rising middle class and increased access to healthcare. This demographic shift is reflected in growing rates of vision disorders, notably myopia. The Asia Pacific region also witnesses a surge in medical tourism, drawing patients from other regions for affordable eye surgeries and treatments. Governments and healthcare providers are investing in ophthalmic infrastructure, fostering a good environment for corneal implant procedures, making the Asia Pacific a dynamic and rapidly expanding segment in the global market.

Competitive Landscape: Global Corneal Implants Market:

  • AJL Ophthalmic S.A.
  • Alcon
  • Aurolab
  • CorneaGen
  • DIOPTEX
  • Eye Care Of San Diego
  • Fortis Hospital Mumbai
  • KeraMed, Inc.
  • Laser & Corneal Surgery Associates
  • Massachusetts Eye and Ear
  • Other Industry Participants

Global Corneal Implants Market Key Insights

Report Specifications Details
Market Revenue in 2022 US$ 402.5 Mn
Market Size Forecast by 2031 US$ 721.7 Mn
Growth Rate (CAGR) 6.1%
Historic Data 2015 – 2021
Base Year for Estimation 2022
Forecast Period 2023 – 2031
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Type, By Surgery Method, By Application, By End-Use
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players AJL Ophthalmic S.A., Alcon, Aurolab, CorneaGen, DIOPTEX, Eye Care of San Diego, Fortis Hospital Mumbai, KeraMed, Inc., Laser & Corneal Surgery Associates, Massachusetts Eye and Ear, Other Industry Participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free):  +81 663-386-8111

South Korea (Toll-Free):  +82-808- 703-126

Saudi Arabia (Toll-Free):  +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

 

Report Coverage & Deliverables

Global Corneal Implants Market

By Type

  • Human Cornea
  • Synthetic

By Surgery Method

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty

By Application

  • Keratoconus
  • Fuchs Dystrophy
  • Infectious Keratitis
  • Corneal Ulcers
  • Others

By End-use

  • Hospitals
  • Ophthalmic Centers
  • Ambulatory Surgical Centers

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2015 – 2021
1.2.2.Base Year: 2022
1.2.3.Forecast Years: 2023 – 2031
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Global Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’s Perspective**
5.Holistic Overview of Corneal Implants Market
6.Market Synopsis: Corneal Implants Market
7.Corneal Implants Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in Corneal Implants Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: Corneal Implants Market
7.6.Porter’s Five Force Analysis
8.Global Corneal Implants Market Analysis and Forecasts, 2023 – 2031
8.1.Overview
8.1.1.Global Corneal Implants Market Revenue (US$ Mn)
8.2.Global Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1.Human Cornea
8.2.1.1.Definition
8.2.1.2.Market Estimation and Penetration, 2015 – 2022
8.2.1.3.Market Forecast, 2023 – 2031
8.2.1.4.Compound Annual Growth Rate (CAGR)
8.2.1.5.Regional Bifurcation
8.2.1.5.1.North America
8.2.1.5.1.1.Market Estimation, 2015 – 2022
8.2.1.5.1.2.Market Forecast, 2023 – 2031
8.2.1.5.2.Europe
8.2.1.5.2.1.Market Estimation, 2015 – 2022
8.2.1.5.2.2.Market Forecast, 2023 – 2031
8.2.1.5.3.Asia Pacific
8.2.1.5.3.1.Market Estimation, 2015 – 2022
8.2.1.5.3.2.Market Forecast, 2023 – 2031
8.2.1.5.4.Middle East and Africa
8.2.1.5.4.1.Market Estimation, 2015 – 2022
8.2.1.5.4.2.Market Forecast, 2023 – 2031
8.2.1.5.5.Latin America
8.2.1.5.5.1.Market Estimation, 2015 – 2022
8.2.1.5.5.2.Market Forecast, 2023 – 2031
8.2.2.Synthetic
8.2.2.1.Definition
8.2.2.2.Market Estimation and Penetration, 2015 – 2022
8.2.2.3.Market Forecast, 2023 – 2031
8.2.2.4.Compound Annual Growth Rate (CAGR)
8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2015 – 2022
8.2.2.5.1.2.Market Forecast, 2023 – 2031
8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2015 – 2022
8.2.2.5.2.2.Market Forecast, 2023 – 2031
8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2015 – 2022
8.2.2.5.3.2.Market Forecast, 2023 – 2031
8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2015 – 2022
8.2.2.5.4.2.Market Forecast, 2023 – 2031
8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2015 – 2022
8.2.2.5.5.2.Market Forecast, 2023 – 2031
8.3.Key Segment for Channeling Investments
8.3.1.By Type
9.Global Corneal Implants Market Analysis and Forecasts, 2023 – 2031
9.1.Overview
9.2.Global Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
9.2.1.Penetrating Keratoplasty
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2015 – 2022
9.2.1.3.Market Forecast, 2023 – 2031
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2015 – 2022
9.2.1.5.1.2.Market Forecast, 2023 – 2031
9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2015 – 2022
9.2.1.5.2.2.Market Forecast, 2023 – 2031
9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2015 – 2022
9.2.1.5.3.2.Market Forecast, 2023 – 2031
9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2015 – 2022
9.2.1.5.4.2.Market Forecast, 2023 – 2031
9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2015 – 2022
9.2.1.5.5.2.Market Forecast, 2023 – 2031
9.2.2.Endothelial Keratoplasty
9.2.2.1.Definition
9.2.2.2.Market Estimation and Penetration, 2015 – 2022
9.2.2.3.Market Forecast, 2023 – 2031
9.2.2.4.Compound Annual Growth Rate (CAGR)
9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2015 – 2022
9.2.2.5.1.2.Market Forecast, 2023 – 2031
9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2015 – 2022
9.2.2.5.2.2.Market Forecast, 2023 – 2031
9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2015 – 2022
9.2.2.5.3.2.Market Forecast, 2023 – 2031
9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2015 – 2022
9.2.2.5.4.2.Market Forecast, 2023 – 2031
9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2015 – 2022
9.2.2.5.5.2.Market Forecast, 2023 – 2031
9.3.Key Segment for Channeling Investments
9.3.1.By Surgery Method
10.Global Corneal Implants Market Analysis and Forecasts, 2023 – 2031
10.1.Overview
10.2.Global Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1.Keratoconus
10.2.1.1.Definition
10.2.1.2.Market Estimation and Penetration, 2015 – 2022
10.2.1.3.Market Forecast, 2023 – 2031
10.2.1.4.Compound Annual Growth Rate (CAGR)
10.2.1.5.Regional Bifurcation
10.2.1.5.1.North America
10.2.1.5.1.1.Market Estimation, 2015 – 2022
10.2.1.5.1.2.Market Forecast, 2023 – 2031
10.2.1.5.2.Europe
10.2.1.5.2.1.Market Estimation, 2015 – 2022
10.2.1.5.2.2.Market Forecast, 2023 – 2031
10.2.1.5.3.Asia Pacific
10.2.1.5.3.1.Market Estimation, 2015 – 2022
10.2.1.5.3.2.Market Forecast, 2023 – 2031
10.2.1.5.4.Middle East and Africa
10.2.1.5.4.1.Market Estimation, 2015 – 2022
10.2.1.5.4.2.Market Forecast, 2023 – 2031
10.2.1.5.5.Latin America
10.2.1.5.5.1.Market Estimation, 2015 – 2022
10.2.1.5.5.2.Market Forecast, 2023 – 2031
10.2.2.Fuchs Dystrophy
10.2.2.1.Definition
10.2.2.2.Market Estimation and Penetration, 2015 – 2022
10.2.2.3.Market Forecast, 2023 – 2031
10.2.2.4.Compound Annual Growth Rate (CAGR)
10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2015 – 2022
10.2.2.5.1.2.Market Forecast, 2023 – 2031
10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2015 – 2022
10.2.2.5.2.2.Market Forecast, 2023 – 2031
10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2015 – 2022
10.2.2.5.3.2.Market Forecast, 2023 – 2031
10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2015 – 2022
10.2.2.5.4.2.Market Forecast, 2023 – 2031
10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2015 – 2022
10.2.2.5.5.2.Market Forecast, 2023 – 2031
10.2.3.Infectious Keratitis
10.2.3.1.Definition
10.2.3.2.Market Estimation and Penetration, 2015 – 2022
10.2.3.3.Market Forecast, 2023 – 2031
10.2.3.4.Compound Annual Growth Rate (CAGR)
10.2.3.5.Regional Bifurcation
10.2.3.5.1.North America
10.2.3.5.1.1.Market Estimation, 2015 – 2022
10.2.3.5.1.2.Market Forecast, 2023 – 2031
10.2.3.5.2.Europe
10.2.3.5.2.1.Market Estimation, 2015 – 2022
10.2.3.5.2.2.Market Forecast, 2023 – 2031
10.2.3.5.3.Asia Pacific
10.2.3.5.3.1.Market Estimation, 2015 – 2022
10.2.3.5.3.2.Market Forecast, 2023 – 2031
10.2.3.5.4.Middle East and Africa
10.2.3.5.4.1.Market Estimation, 2015 – 2022
10.2.3.5.4.2.Market Forecast, 2023 – 2031
10.2.3.5.5.Latin America
10.2.3.5.5.1.Market Estimation, 2015 – 2022
10.2.3.5.5.2.Market Forecast, 2023 – 2031
10.2.4.Corneal Ulcers
10.2.4.1.Definition
10.2.4.2.Market Estimation and Penetration, 2015 – 2022
10.2.4.3.Market Forecast, 2023 – 2031
10.2.4.4.Compound Annual Growth Rate (CAGR)
10.2.4.5.Regional Bifurcation
10.2.4.5.1.North America
10.2.4.5.1.1.Market Estimation, 2015 – 2022
10.2.4.5.1.2.Market Forecast, 2023 – 2031
10.2.4.5.2.Europe
10.2.4.5.2.1.Market Estimation, 2015 – 2022
10.2.4.5.2.2.Market Forecast, 2023 – 2031
10.2.4.5.3.Asia Pacific
10.2.4.5.3.1.Market Estimation, 2015 – 2022
10.2.4.5.3.2.Market Forecast, 2023 – 2031
10.2.4.5.4.Middle East and Africa
10.2.4.5.4.1.Market Estimation, 2015 – 2022
10.2.4.5.4.2.Market Forecast, 2023 – 2031
10.2.4.5.5.Latin America
10.2.4.5.5.1.Market Estimation, 2015 – 2022
10.2.4.5.5.2.Market Forecast, 2023 – 2031
10.2.5.Others
10.2.5.1.Definition
10.2.5.2.Market Estimation and Penetration, 2015 – 2022
10.2.5.3.Market Forecast, 2023 – 2031
10.2.5.4.Compound Annual Growth Rate (CAGR)
10.2.5.5.Regional Bifurcation
10.2.5.5.1.North America
10.2.5.5.1.1.Market Estimation, 2015 – 2022
10.2.5.5.1.2.Market Forecast, 2023 – 2031
10.2.5.5.2.Europe
10.2.5.5.2.1.Market Estimation, 2015 – 2022
10.2.5.5.2.2.Market Forecast, 2023 – 2031
10.2.5.5.3.Asia Pacific
10.2.5.5.3.1.Market Estimation, 2015 – 2022
10.2.5.5.3.2.Market Forecast, 2023 – 2031
10.2.5.5.4.Middle East and Africa
10.2.5.5.4.1.Market Estimation, 2015 – 2022
10.2.5.5.4.2.Market Forecast, 2023 – 2031
10.2.5.5.5.Latin America
10.2.5.5.5.1.Market Estimation, 2015 – 2022
10.2.5.5.5.2.Market Forecast, 2023 – 2031
10.3.Key Segment for Channeling Investments
10.3.1.By Application
11.Global Corneal Implants Market Analysis and Forecasts, 2023 – 2031
11.1.Overview
11.2.Global Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
11.2.1.Hospitals
11.2.1.1.Definition
11.2.1.2.Market Estimation and Penetration, 2015 – 2022
11.2.1.3.Market Forecast, 2023 – 2031
11.2.1.4.Compound Annual Growth Rate (CAGR)
11.2.1.5.Regional Bifurcation
11.2.1.5.1.North America
11.2.1.5.1.1.Market Estimation, 2015 – 2022
11.2.1.5.1.2.Market Forecast, 2023 – 2031
11.2.1.5.2.Europe
11.2.1.5.2.1.Market Estimation, 2015 – 2022
11.2.1.5.2.2.Market Forecast, 2023 – 2031
11.2.1.5.3.Asia Pacific
11.2.1.5.3.1.Market Estimation, 2015 – 2022
11.2.1.5.3.2.Market Forecast, 2023 – 2031
11.2.1.5.4.Middle East and Africa
11.2.1.5.4.1.Market Estimation, 2015 – 2022
11.2.1.5.4.2.Market Forecast, 2023 – 2031
11.2.1.5.5.Latin America
11.2.1.5.5.1.Market Estimation, 2015 – 2022
11.2.1.5.5.2.Market Forecast, 2023 – 2031
11.2.2.Ophthalmic Centers
11.2.2.1.Definition
11.2.2.2.Market Estimation and Penetration, 2015 – 2022
11.2.2.3.Market Forecast, 2023 – 2031
11.2.2.4.Compound Annual Growth Rate (CAGR)
11.2.2.5.Regional Bifurcation
11.2.2.5.1.North America
11.2.2.5.1.1.Market Estimation, 2015 – 2022
11.2.2.5.1.2.Market Forecast, 2023 – 2031
11.2.2.5.2.Europe
11.2.2.5.2.1.Market Estimation, 2015 – 2022
11.2.2.5.2.2.Market Forecast, 2023 – 2031
11.2.2.5.3.Asia Pacific
11.2.2.5.3.1.Market Estimation, 2015 – 2022
11.2.2.5.3.2.Market Forecast, 2023 – 2031
11.2.2.5.4.Middle East and Africa
11.2.2.5.4.1.Market Estimation, 2015 – 2022
11.2.2.5.4.2.Market Forecast, 2023 – 2031
11.2.2.5.5.Latin America
11.2.2.5.5.1.Market Estimation, 2015 – 2022
11.2.2.5.5.2.Market Forecast, 2023 – 2031
11.2.3.Ambulatory Surgical Centers
11.2.3.1.Definition
11.2.3.2.Market Estimation and Penetration, 2015 – 2022
11.2.3.3.Market Forecast, 2023 – 2031
11.2.3.4.Compound Annual Growth Rate (CAGR)
11.2.3.5.Regional Bifurcation
11.2.3.5.1.North America
11.2.3.5.1.1.Market Estimation, 2015 – 2022
11.2.3.5.1.2.Market Forecast, 2023 – 2031
11.2.3.5.2.Europe
11.2.3.5.2.1.Market Estimation, 2015 – 2022
11.2.3.5.2.2.Market Forecast, 2023 – 2031
11.2.3.5.3.Asia Pacific
11.2.3.5.3.1.Market Estimation, 2015 – 2022
11.2.3.5.3.2.Market Forecast, 2023 – 2031
11.2.3.5.4.Middle East and Africa
11.2.3.5.4.1.Market Estimation, 2015 – 2022
11.2.3.5.4.2.Market Forecast, 2023 – 2031
11.2.3.5.5.Latin America
11.2.3.5.5.1.Market Estimation, 2015 – 2022
11.2.3.5.5.2.Market Forecast, 2023 – 2031
11.3.Key Segment for Channeling Investments
11.3.1.By End-use
12.North America Corneal Implants Market Analysis and Forecasts, 2023 – 2031
12.1.Overview
12.1.1.North America Corneal Implants Market Revenue (US$ Mn)
12.2.North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1.Human Cornea
12.2.2.Synthetic
12.3.North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
12.3.1.Penetrating Keratoplasty
12.3.2.Endothelial Keratoplasty
12.4.North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1.Keratoconus
12.4.2.Fuchs Dystrophy
12.4.3.Infectious Keratitis
12.4.4.Corneal Ulcers
12.4.5.Others
12.5.North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
12.5.1.Hospitals
12.5.2.Ophthalmic Centers
12.5.3.Ambulatory Surgical Centers
12.6.North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1.U.S
12.6.1.1.U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
12.6.1.1.1.Human Cornea
12.6.1.1.2.Synthetic
12.6.1.2.U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
12.6.1.2.1.Penetrating Keratoplasty
12.6.1.2.2.Endothelial Keratoplasty
12.6.1.3.U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.3.1.Keratoconus
12.6.1.3.2.Fuchs Dystrophy
12.6.1.3.3.Infectious Keratitis
12.6.1.3.4.Corneal Ulcers
12.6.1.3.5.Others
12.6.1.4.U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
12.6.1.4.1.Hospitals
12.6.1.4.2.Ophthalmic Centers
12.6.1.4.3.Ambulatory Surgical Centers
12.6.2.Canada
12.6.2.1.Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
12.6.2.1.1.Human Cornea
12.6.2.1.2.Synthetic
12.6.2.2.Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
12.6.2.2.1.Penetrating Keratoplasty
12.6.2.2.2.Endothelial Keratoplasty
12.6.2.3.Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.3.1.Keratoconus
12.6.2.3.2.Fuchs Dystrophy
12.6.2.3.3.Infectious Keratitis
12.6.2.3.4.Corneal Ulcers
12.6.2.3.5.Others
12.6.2.4.Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
12.6.2.4.1.Hospitals
12.6.2.4.2.Ophthalmic Centers
12.6.2.4.3.Ambulatory Surgical Centers
12.6.3.Mexico
12.6.3.1.Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
12.6.3.1.1.Human Cornea
12.6.3.1.2.Synthetic
12.6.3.2.Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
12.6.3.2.1.Penetrating Keratoplasty
12.6.3.2.2.Endothelial Keratoplasty
12.6.3.3.Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.3.1.Keratoconus
12.6.3.3.2.Fuchs Dystrophy
12.6.3.3.3.Infectious Keratitis
12.6.3.3.4.Corneal Ulcers
12.6.3.3.5.Others
12.6.3.4.Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
12.6.3.4.1.Hospitals
12.6.3.4.2.Ophthalmic Centers
12.6.3.4.3.Ambulatory Surgical Centers
12.6.4.Rest of North America
12.6.4.1.Rest of North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
12.6.4.1.1.Human Cornea
12.6.4.1.2.Synthetic
12.6.4.2.Rest of North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
12.6.4.2.1.Penetrating Keratoplasty
12.6.4.2.2.Endothelial Keratoplasty
12.6.4.3.Rest of North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1.Keratoconus
12.6.4.3.2.Fuchs Dystrophy
12.6.4.3.3.Infectious Keratitis
12.6.4.3.4.Corneal Ulcers
12.6.4.3.5.Others
12.6.4.4.Rest of North America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
12.6.4.4.1.Hospitals
12.6.4.4.2.Ophthalmic Centers
12.6.4.4.3.Ambulatory Surgical Centers
12.7.Key Segment for Channeling Investments
12.7.1.By Country
12.7.2.By Type
12.7.3.By Surgery Method
12.7.4.By Application
12.7.5.By End-use
13.Europe Corneal Implants Market Analysis and Forecasts, 2023 – 2031
13.1.Overview
13.1.1.Europe Corneal Implants Market Revenue (US$ Mn)
13.2.Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1.Human Cornea
13.2.2.Synthetic
13.3.Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.3.1.Penetrating Keratoplasty
13.3.2.Endothelial Keratoplasty
13.4.Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1.Keratoconus
13.4.2.Fuchs Dystrophy
13.4.3.Infectious Keratitis
13.4.4.Corneal Ulcers
13.4.5.Others
13.5.Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.5.1.Hospitals
13.5.2.Ophthalmic Centers
13.5.3.Ambulatory Surgical Centers
13.6.Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1.France
13.6.1.1.France Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.1.1.1.Human Cornea
13.6.1.1.2.Synthetic
13.6.1.2.France Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.1.2.1.Penetrating Keratoplasty
13.6.1.2.2.Endothelial Keratoplasty
13.6.1.3.France Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.3.1.Keratoconus
13.6.1.3.2.Fuchs Dystrophy
13.6.1.3.3.Infectious Keratitis
13.6.1.3.4.Corneal Ulcers
13.6.1.3.5.Others
13.6.1.4.France Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.1.4.1.Hospitals
13.6.1.4.2.Ophthalmic Centers
13.6.1.4.3.Ambulatory Surgical Centers
13.6.2.The UK
13.6.2.1.The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.2.1.1.Human Cornea
13.6.2.1.2.Synthetic
13.6.2.2.The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.2.2.1.Penetrating Keratoplasty
13.6.2.2.2.Endothelial Keratoplasty
13.6.2.3.The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.2.3.1.Keratoconus
13.6.2.3.2.Fuchs Dystrophy
13.6.2.3.3.Infectious Keratitis
13.6.2.3.4.Corneal Ulcers
13.6.2.3.5.Others
13.6.2.4.The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.2.4.1.Hospitals
13.6.2.4.2.Ophthalmic Centers
13.6.2.4.3.Ambulatory Surgical Centers
13.6.3.Spain
13.6.3.1.Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.3.1.1.Human Cornea
13.6.3.1.2.Synthetic
13.6.3.2.Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.3.2.1.Penetrating Keratoplasty
13.6.3.2.2.Endothelial Keratoplasty
13.6.3.3.Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.3.1.Keratoconus
13.6.3.3.2.Fuchs Dystrophy
13.6.3.3.3.Infectious Keratitis
13.6.3.3.4.Corneal Ulcers
13.6.3.3.5.Others
13.6.3.4.Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.3.4.1.Hospitals
13.6.3.4.2.Ophthalmic Centers
13.6.3.4.3.Ambulatory Surgical Centers
13.6.4.Germany
13.6.4.1.Germany Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.4.1.1.Human Cornea
13.6.4.1.2.Synthetic
13.6.4.2.Germany Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.4.2.1.Penetrating Keratoplasty
13.6.4.2.2.Endothelial Keratoplasty
13.6.4.3.Germany Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.3.1.Keratoconus
13.6.4.3.2.Fuchs Dystrophy
13.6.4.3.3.Infectious Keratitis
13.6.4.3.4.Corneal Ulcers
13.6.4.3.5.Others
13.6.4.4.Germany Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.4.4.1.Hospitals
13.6.4.4.2.Ophthalmic Centers
13.6.4.4.3.Ambulatory Surgical Centers
13.6.5.Italy
13.6.5.1.Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.5.1.1.Human Cornea
13.6.5.1.2.Synthetic
13.6.5.2.Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.5.2.1.Penetrating Keratoplasty
13.6.5.2.2.Endothelial Keratoplasty
13.6.5.3.Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.3.1.Keratoconus
13.6.5.3.2.Fuchs Dystrophy
13.6.5.3.3.Infectious Keratitis
13.6.5.3.4.Corneal Ulcers
13.6.5.3.5.Others
13.6.5.4.Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.5.4.1.Hospitals
13.6.5.4.2.Ophthalmic Centers
13.6.5.4.3.Ambulatory Surgical Centers
13.6.6.Nordic Countries
13.6.6.1.Nordic Countries Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.6.1.1.Human Cornea
13.6.6.1.2.Synthetic
13.6.6.2.Nordic Countries Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.6.2.1.Penetrating Keratoplasty
13.6.6.2.2.Endothelial Keratoplasty
13.6.6.3.Nordic Countries Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.3.1.Keratoconus
13.6.6.3.2.Fuchs Dystrophy
13.6.6.3.3.Infectious Keratitis
13.6.6.3.4.Corneal Ulcers
13.6.6.3.5.Others
13.6.6.4.Nordic Countries Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.6.4.1.Hospitals
13.6.6.4.2.Ophthalmic Centers
13.6.6.4.3.Ambulatory Surgical Centers
13.6.6.5.Nordic Countries Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1.Denmark
13.6.6.5.2.Finland
13.6.6.5.3.Iceland
13.6.6.5.4.Sweden
13.6.6.5.5.Norway
13.6.7.Benelux Union
13.6.7.1.Benelux Union Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.7.1.1.Human Cornea
13.6.7.1.2.Synthetic
13.6.7.2.Benelux Union Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.7.2.1.Penetrating Keratoplasty
13.6.7.2.2.Endothelial Keratoplasty
13.6.7.3.Benelux Union Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.3.1.Keratoconus
13.6.7.3.2.Fuchs Dystrophy
13.6.7.3.3.Infectious Keratitis
13.6.7.3.4.Corneal Ulcers
13.6.7.3.5.Others
13.6.7.4.Benelux Union Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.7.4.1.Hospitals
13.6.7.4.2.Ophthalmic Centers
13.6.7.4.3.Ambulatory Surgical Centers
13.6.7.5.Benelux Union Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.Belgium
13.6.7.5.2.The Netherlands
13.6.7.5.3.Luxembourg
13.6.8.Rest of Europe
13.6.8.1.Rest of Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.6.8.1.1.Human Cornea
13.6.8.1.2.Synthetic
13.6.8.2.Rest of Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
13.6.8.2.1.Penetrating Keratoplasty
13.6.8.2.2.Endothelial Keratoplasty
13.6.8.3.Rest of Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1.Keratoconus
13.6.8.3.2.Fuchs Dystrophy
13.6.8.3.3.Infectious Keratitis
13.6.8.3.4.Corneal Ulcers
13.6.8.3.5.Others
13.6.8.4.Rest of Europe Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
13.6.8.4.1.Hospitals
13.6.8.4.2.Ophthalmic Centers
13.6.8.4.3.Ambulatory Surgical Centers
13.7.Key Segment for Channeling Investments
13.7.1.By Country
13.7.2.By Type
13.7.3.By Surgery Method
13.7.4.By Application
13.7.5.By End-use
14.Asia Pacific Corneal Implants Market Analysis and Forecasts, 2023 – 2031
14.1.Overview
14.1.1.Asia Pacific Corneal Implants Market Revenue (US$ Mn)
14.2.Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1.Human Cornea
14.2.2.Synthetic
14.3.Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.3.1.Penetrating Keratoplasty
14.3.2.Endothelial Keratoplasty
14.4.Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1.Keratoconus
14.4.2.Fuchs Dystrophy
14.4.3.Infectious Keratitis
14.4.4.Corneal Ulcers
14.4.5.Others
14.5.Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.5.1.Hospitals
14.5.2.Ophthalmic Centers
14.5.3.Ambulatory Surgical Centers
14.6.Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1.China
14.6.1.1.China Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.1.1.1.Human Cornea
14.6.1.1.2.Synthetic
14.6.1.2.China Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.1.2.1.Penetrating Keratoplasty
14.6.1.2.2.Endothelial Keratoplasty
14.6.1.3.China Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.3.1.Keratoconus
14.6.1.3.2.Fuchs Dystrophy
14.6.1.3.3.Infectious Keratitis
14.6.1.3.4.Corneal Ulcers
14.6.1.3.5.Others
14.6.1.4.China Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.1.4.1.Hospitals
14.6.1.4.2.Ophthalmic Centers
14.6.1.4.3.Ambulatory Surgical Centers
14.6.2.Japan
14.6.2.1.Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.2.1.1.Human Cornea
14.6.2.1.2.Synthetic
14.6.2.2.Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.2.2.1.Penetrating Keratoplasty
14.6.2.2.2.Endothelial Keratoplasty
14.6.2.3.Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.3.1.Keratoconus
14.6.2.3.2.Fuchs Dystrophy
14.6.2.3.3.Infectious Keratitis
14.6.2.3.4.Corneal Ulcers
14.6.2.3.5.Others
14.6.2.4.Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.2.4.1.Hospitals
14.6.2.4.2.Ophthalmic Centers
14.6.2.4.3.Ambulatory Surgical Centers
14.6.3.India
14.6.3.1.India Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.3.1.1.Human Cornea
14.6.3.1.2.Synthetic
14.6.3.2.India Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.3.2.1.Penetrating Keratoplasty
14.6.3.2.2.Endothelial Keratoplasty
14.6.3.3.India Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.3.1.Keratoconus
14.6.3.3.2.Fuchs Dystrophy
14.6.3.3.3.Infectious Keratitis
14.6.3.3.4.Corneal Ulcers
14.6.3.3.5.Others
14.6.3.4.India Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.3.4.1.Hospitals
14.6.3.4.2.Ophthalmic Centers
14.6.3.4.3.Ambulatory Surgical Centers
14.6.4.New Zealand
14.6.4.1.New Zealand Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.4.1.1.Human Cornea
14.6.4.1.2.Synthetic
14.6.4.2.New Zealand Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.4.2.1.Penetrating Keratoplasty
14.6.4.2.2.Endothelial Keratoplasty
14.6.4.3.New Zealand Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.3.1.Keratoconus
14.6.4.3.2.Fuchs Dystrophy
14.6.4.3.3.Infectious Keratitis
14.6.4.3.4.Corneal Ulcers
14.6.4.3.5.Others
14.6.4.4.New Zealand Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.4.4.1.Hospitals
14.6.4.4.2.Ophthalmic Centers
14.6.4.4.3.Ambulatory Surgical Centers
14.6.5.Australia
14.6.5.1.Australia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.5.1.1.Human Cornea
14.6.5.1.2.Synthetic
14.6.5.2.Australia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.5.2.1.Penetrating Keratoplasty
14.6.5.2.2.Endothelial Keratoplasty
14.6.5.3.Australia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.3.1.Keratoconus
14.6.5.3.2.Fuchs Dystrophy
14.6.5.3.3.Infectious Keratitis
14.6.5.3.4.Corneal Ulcers
14.6.5.3.5.Others
14.6.5.4.Australia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.5.4.1.Hospitals
14.6.5.4.2.Ophthalmic Centers
14.6.5.4.3.Ambulatory Surgical Centers
14.6.6.South Korea
14.6.6.1.South Korea Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.6.1.1.Human Cornea
14.6.6.1.2.Synthetic
14.6.6.2.South Korea Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.6.2.1.Penetrating Keratoplasty
14.6.6.2.2.Endothelial Keratoplasty
14.6.6.3.South Korea Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.3.1.Keratoconus
14.6.6.3.2.Fuchs Dystrophy
14.6.6.3.3.Infectious Keratitis
14.6.6.3.4.Corneal Ulcers
14.6.6.3.5.Others
14.6.6.4.South Korea Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.6.4.1.Hospitals
14.6.6.4.2.Ophthalmic Centers
14.6.6.4.3.Ambulatory Surgical Centers
14.6.7.Southeast Asia
14.6.7.1.Southeast Asia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.7.1.1.Human Cornea
14.6.7.1.2.Synthetic
14.6.7.2.Southeast Asia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.7.2.1.Penetrating Keratoplasty
14.6.7.2.2.Endothelial Keratoplasty
14.6.7.3.Southeast Asia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1.Keratoconus
14.6.7.3.2.Fuchs Dystrophy
14.6.7.3.3.Infectious Keratitis
14.6.7.3.4.Corneal Ulcers
14.6.7.3.5.Others
14.6.7.4.Southeast Asia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.7.4.1.Hospitals
14.6.7.4.2.Ophthalmic Centers
14.6.7.4.3.Ambulatory Surgical Centers
14.6.7.5.Southeast Asia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1.Indonesia
14.6.7.5.2.Thailand
14.6.7.5.3.Malaysia
14.6.7.5.4.Singapore
14.6.7.5.5.Rest of Southeast Asia
14.6.8.Rest of Asia Pacific
14.6.8.1.Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.6.8.1.1.Human Cornea
14.6.8.1.2.Synthetic
14.6.8.2.Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
14.6.8.2.1.Penetrating Keratoplasty
14.6.8.2.2.Endothelial Keratoplasty
14.6.8.3.Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1.Keratoconus
14.6.8.3.2.Fuchs Dystrophy
14.6.8.3.3.Infectious Keratitis
14.6.8.3.4.Corneal Ulcers
14.6.8.3.5.Others
14.6.8.4.Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
14.6.8.4.1.Hospitals
14.6.8.4.2.Ophthalmic Centers
14.6.8.4.3.Ambulatory Surgical Centers
14.7.Key Segment for Channeling Investments
14.7.1.By Country
14.7.2.By Type
14.7.3.By Surgery Method
14.7.4.By Application
14.7.5.By End-use
15.Middle East and Africa Corneal Implants Market Analysis and Forecasts, 2023 – 2031
15.1.Overview
15.1.1.Middle East and Africa Corneal Implants Market Revenue (US$ Mn)
15.2.Middle East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1.Human Cornea
15.2.2.Synthetic
15.3.Middle East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
15.3.1.Penetrating Keratoplasty
15.3.2.Endothelial Keratoplasty
15.4.Middle East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1.Keratoconus
15.4.2.Fuchs Dystrophy
15.4.3.Infectious Keratitis
15.4.4.Corneal Ulcers
15.4.5.Others
15.5.Middle East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
15.5.1.Hospitals
15.5.2.Ophthalmic Centers
15.5.3.Ambulatory Surgical Centers
15.6.Middle East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1.Saudi Arabia
15.6.1.1.Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.6.1.1.1.Human Cornea
15.6.1.1.2.Synthetic
15.6.1.2.Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
15.6.1.2.1.Penetrating Keratoplasty
15.6.1.2.2.Endothelial Keratoplasty
15.6.1.3.Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.3.1.Keratoconus
15.6.1.3.2.Fuchs Dystrophy
15.6.1.3.3.Infectious Keratitis
15.6.1.3.4.Corneal Ulcers
15.6.1.3.5.Others
15.6.1.4.Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
15.6.1.4.1.Hospitals
15.6.1.4.2.Ophthalmic Centers
15.6.1.4.3.Ambulatory Surgical Centers
15.6.2.UAE
15.6.2.1.UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.6.2.1.1.Human Cornea
15.6.2.1.2.Synthetic
15.6.2.2.UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
15.6.2.2.1.Penetrating Keratoplasty
15.6.2.2.2.Endothelial Keratoplasty
15.6.2.3.UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.3.1.Keratoconus
15.6.2.3.2.Fuchs Dystrophy
15.6.2.3.3.Infectious Keratitis
15.6.2.3.4.Corneal Ulcers
15.6.2.3.5.Others
15.6.2.4.UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
15.6.2.4.1.Hospitals
15.6.2.4.2.Ophthalmic Centers
15.6.2.4.3.Ambulatory Surgical Centers
15.6.3.Egypt
15.6.3.1.Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.6.3.1.1.Human Cornea
15.6.3.1.2.Synthetic
15.6.3.2.Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
15.6.3.2.1.Penetrating Keratoplasty
15.6.3.2.2.Endothelial Keratoplasty
15.6.3.3.Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.3.1.Keratoconus
15.6.3.3.2.Fuchs Dystrophy
15.6.3.3.3.Infectious Keratitis
15.6.3.3.4.Corneal Ulcers
15.6.3.3.5.Others
15.6.3.4.Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
15.6.3.4.1.Hospitals
15.6.3.4.2.Ophthalmic Centers
15.6.3.4.3.Ambulatory Surgical Centers
15.6.4.Kuwait
15.6.4.1.Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.6.4.1.1.Human Cornea
15.6.4.1.2.Synthetic
15.6.4.2.Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
15.6.4.2.1.Penetrating Keratoplasty
15.6.4.2.2.Endothelial Keratoplasty
15.6.4.3.Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.3.1.Keratoconus
15.6.4.3.2.Fuchs Dystrophy
15.6.4.3.3.Infectious Keratitis
15.6.4.3.4.Corneal Ulcers
15.6.4.3.5.Others
15.6.4.4.Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
15.6.4.4.1.Hospitals
15.6.4.4.2.Ophthalmic Centers
15.6.4.4.3.Ambulatory Surgical Centers
15.6.5.South Africa
15.6.5.1.South Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.6.5.1.1.Human Cornea
15.6.5.1.2.Synthetic
15.6.5.2.South Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
15.6.5.2.1.Penetrating Keratoplasty
15.6.5.2.2.Endothelial Keratoplasty
15.6.5.3.South Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.3.1.Keratoconus
15.6.5.3.2.Fuchs Dystrophy
15.6.5.3.3.Infectious Keratitis
15.6.5.3.4.Corneal Ulcers
15.6.5.3.5.Others
15.6.5.4.South Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
15.6.5.4.1.Hospitals
15.6.5.4.2.Ophthalmic Centers
15.6.5.4.3.Ambulatory Surgical Centers
15.6.6.Rest of Middle East & Africa
15.6.6.1.Rest of Middle East & Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.6.6.1.1.Human Cornea
15.6.6.1.2.Synthetic
15.6.6.2.Rest of Middle East & Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
15.6.6.2.1.Penetrating Keratoplasty
15.6.6.2.2.Endothelial Keratoplasty
15.6.6.3.Rest of Middle East & Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1.Keratoconus
15.6.6.3.2.Fuchs Dystrophy
15.6.6.3.3.Infectious Keratitis
15.6.6.3.4.Corneal Ulcers
15.6.6.3.5.Others
15.6.6.4.Rest of Middle East & Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
15.6.6.4.1.Hospitals
15.6.6.4.2.Ophthalmic Centers
15.6.6.4.3.Ambulatory Surgical Centers
15.7.Key Segment for Channeling Investments
15.7.1.By Country
15.7.2.By Type
15.7.3.By Surgery Method
15.7.4.By Application
15.7.5.By End-use
16.Latin America Corneal Implants Market Analysis and Forecasts, 2023 – 2031
16.1.Overview
16.1.1.Latin America Corneal Implants Market Revenue (US$ Mn)
16.2.Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
16.2.1.Human Cornea
16.2.2.Synthetic
16.3.Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
16.3.1.Penetrating Keratoplasty
16.3.2.Endothelial Keratoplasty
16.4.Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
16.4.1.Keratoconus
16.4.2.Fuchs Dystrophy
16.4.3.Infectious Keratitis
16.4.4.Corneal Ulcers
16.4.5.Others
16.5.Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
16.5.1.Hospitals
16.5.2.Ophthalmic Centers
16.5.3.Ambulatory Surgical Centers
16.6.Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1.Brazil
16.6.1.1.Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
16.6.1.1.1.Human Cornea
16.6.1.1.2.Synthetic
16.6.1.2.Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
16.6.1.2.1.Penetrating Keratoplasty
16.6.1.2.2.Endothelial Keratoplasty
16.6.1.3.Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.3.1.Keratoconus
16.6.1.3.2.Fuchs Dystrophy
16.6.1.3.3.Infectious Keratitis
16.6.1.3.4.Corneal Ulcers
16.6.1.3.5.Others
16.6.1.4.Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
16.6.1.4.1.Hospitals
16.6.1.4.2.Ophthalmic Centers
16.6.1.4.3.Ambulatory Surgical Centers
16.6.2.Argentina
16.6.2.1.Argentina Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
16.6.2.1.1.Human Cornea
16.6.2.1.2.Synthetic
16.6.2.2.Argentina Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
16.6.2.2.1.Penetrating Keratoplasty
16.6.2.2.2.Endothelial Keratoplasty
16.6.2.3.Argentina Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.3.1.Keratoconus
16.6.2.3.2.Fuchs Dystrophy
16.6.2.3.3.Infectious Keratitis
16.6.2.3.4.Corneal Ulcers
16.6.2.3.5.Others
16.6.2.4.Argentina Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
16.6.2.4.1.Hospitals
16.6.2.4.2.Ophthalmic Centers
16.6.2.4.3.Ambulatory Surgical Centers
16.6.3.Rest of Latin America
16.6.3.1.Rest of Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
16.6.3.1.1.Human Cornea
16.6.3.1.2.Synthetic
16.6.3.2.Rest of Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Surgery Method
16.6.3.2.1.Penetrating Keratoplasty
16.6.3.2.2.Endothelial Keratoplasty
16.6.3.3.Rest of Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1.Keratoconus
16.6.3.3.2.Fuchs Dystrophy
16.6.3.3.3.Infectious Keratitis
16.6.3.3.4.Corneal Ulcers
16.6.3.3.5.Others
16.6.3.4.Rest of Latin America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End-use
16.6.3.4.1.Hospitals
16.6.3.4.2.Ophthalmic Centers
16.6.3.4.3.Ambulatory Surgical Centers
16.7.Key Segment for Channeling Investments
16.7.1.By Country
16.7.2.By Type
16.7.3.By Surgery Method
16.7.4.By Application
16.7.5.By End-use
17.Competitive Benchmarking
17.1.Market Share Analysis, 2022
17.2.Global Presence and Growth Strategies
17.2.1.Mergers and Acquisitions
17.2.2.Product Launches
17.2.3.Investments Trends
17.2.4.R&D Initiatives
18.Player Profiles
18.1.AJL Ophthalmic S.A.
18.1.1.Company Details
18.1.2.Company Overview
18.1.3.Product Offerings
18.1.4.Key Developments
18.1.5.Financial Analysis
18.1.6.SWOT Analysis
18.1.7.Business Strategies
18.2.Alcon
18.2.1.Company Details
18.2.2.Company Overview
18.2.3.Product Offerings
18.2.4.Key Developments
18.2.5.Financial Analysis
18.2.6.SWOT Analysis
18.2.7.Business Strategies
18.3.Aurolab
18.3.1.Company Details
18.3.2.Company Overview
18.3.3.Product Offerings
18.3.4.Key Developments
18.3.5.Financial Analysis
18.3.6.SWOT Analysis
18.3.7.Business Strategies
18.4.CorneaGen
18.4.1.Company Details
18.4.2.Company Overview
18.4.3.Product Offerings
18.4.4.Key Developments
18.4.5.Financial Analysis
18.4.6.SWOT Analysis
18.4.7.Business Strategies
18.5.DIOPTEX
18.5.1.Company Details
18.5.2.Company Overview
18.5.3.Product Offerings
18.5.4.Key Developments
18.5.5.Financial Analysis
18.5.6.SWOT Analysis
18.5.7.Business Strategies
18.6.Eye Care Of San Diego
18.6.1.Company Details
18.6.2.Company Overview
18.6.3.Product Offerings
18.6.4.Key Developments
18.6.5.Financial Analysis
18.6.6.SWOT Analysis
18.6.7.Business Strategies
18.7.Fortis Hospital Mumbai
18.7.1.Company Details
18.7.2.Company Overview
18.7.3.Product Offerings
18.7.4.Key Developments
18.7.5.Financial Analysis
18.7.6.SWOT Analysis
18.7.7.Business Strategies
18.8.KeraMed, Inc.
18.8.1.Company Details
18.8.2.Company Overview
18.8.3.Product Offerings
18.8.4.Key Developments
18.8.5.Financial Analysis
18.8.6.SWOT Analysis
18.8.7.Business Strategies
18.9.Laser & Corneal Surgery Associates
18.9.1.Company Details
18.9.2.Company Overview
18.9.3.Product Offerings
18.9.4.Key Developments
18.9.5.Financial Analysis
18.9.6.SWOT Analysis
18.9.7.Business Strategies
18.10.Massachusetts Eye and Ear
18.10.1.Company Details
18.10.2.Company Overview
18.10.3.Product Offerings
18.10.4.Key Developments
18.10.5.Financial Analysis
18.10.6.SWOT Analysis
18.10.7.Business Strategies
18.11.Other Market Participants
19.Key Findings

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.

Global Corneal Implants Market

By Type

  • Human Cornea
  • Synthetic

By Surgery Method

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty

By Application

  • Keratoconus
  • Fuchs Dystrophy
  • Infectious Keratitis
  • Corneal Ulcers
  • Others

By End-use

  • Hospitals
  • Ophthalmic Centers
  • Ambulatory Surgical Centers

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.

.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Corneal Implants Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top